CME's diversified volume growth and product innovation underpin Q3 results.
Context
What happened: CME Group (NASDAQ:CME) reported Q3 2026 revenue above analyst estimates, with sales up 13% year on year and adjusted EPS slightly ahead of consensus.
Key numbers: Revenue $1.74 billion vs $1.72 billion estimated (0.9% beat). Adjusted EPS $3.02 vs $2.99 estimated.
Why it matters: Management cited record third-quarter average daily volume across all six asset classes, a record quarter for market data revenue, and pointed to product innovation, Treasury clearing changes, and 24/7 trading expansion as central to its strategy. The results drew little market reaction.
Market: +0.2% today ($295.79), +12.9% YTD, 1.0x vol — as of 11:15 UTC
← Dashboard
Oct 22, 2026 11:18 AM ET